Novel Device May Enhance Chemotherapy Treatment In Brain Tumors
NovoCure Ltd. presented results evaluating the Novo-TTF device in vitro and in a pilot clinical trial that showed the device enhanced the efficacy of standard chemotherapy (temozolomide) treatment in newly-diagnosed glioblastoma multiforme (GBM) patients.
More: continued here
Filed under: Cancer on November 27th, 2008